Tag Archives: TGA

Launch of TGA Advertising Hub – Initial experience of submitting complaints

The TGA Advertising hub still notes: “We are experiencing intermittent IT issues that are impacting this form. If you experience an error lodging a complaint, please try again later. We are working to fix this issue as a matter of … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted

Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications

See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment

TGA response to criticism of new complaint handling system; my comment

See: https://www.theguardian.com/australia-news/2018/jun/05/consumers-wont-know-about-dodgy-drug-ads-under-new-complaints-system-experts-warn The TGA media spokesperson said: “The new system will be more transparent than the previous one, apart from publication of TGA’s performance against key performance indicators detailed information on individual complaints will be published for medium-, serious- and critical-level … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , | Leave a comment

Choice takes campaign to disallow the Permissible Indications Determination to Canberra

Katinka Day, Choice Campaigns and Policy Team Lead, delivers mock-ups of shonky products allowed by the TGA’s permissible indications determination to Senators, see: https://campaigns.choice.com.au/tga-fact-over-fiction/ https://ajp.com.au/news/choice-calls-out-supplement-claims/ http://www.medreach.com.au/?p=2594 by

Posted in Complementary medicine, Education, Medicine policy, Natural Therapies, Pharmaceutical Promotion, Senate | Tagged , , , | Leave a comment

Campaign to disallow the Therapeutic Goods (Permissible Indications) Determination No.1 of 2018

The Therapeutic Goods (Permissible Indications) Determination No.1 of 2018 is currently on the Senate Disallowable Instruments List until 25 June 2018. Friends of Science in Medicine (FSM) have joined Choice (the Australian Consumers’ Association) and other civil society organisations to petition … Continue reading

Posted in Complementary medicine, Education, Medicine policy | Tagged , , , , , , , , | Leave a comment

TGA Consultation: Complaint handling and monitoring

Yet another TGA consultation; this one closing on 4 June 2018 for a new regulatory system that is meant to start on 1 July 2018! For the last one on the draft new Therapeutic Goods Advertising Code, see my comments … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA Consultation: Draft therapeutic goods advertising code 2018 #2

For background, see TGA Consultation: Draft therapeutic goods advertising code 2018 #1 Our full submission is available here. It’s endorsed by Friends of Science in Medicine (FSM) and the writing was assisted by two Monash University students, Malcolm Vickers (MPH) and … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA Consultation: Draft therapeutic goods advertising code 2018 #1

The TGA is seeking comments from interested parties on the proposed draft Therapeutic Goods Advertising Code 2018 (the Code) and associated guidance document. Comments should be submitted to the TGA by COB Friday 27 April. Typically, many suggestions to improve the … Continue reading

Posted in Complementary medicine, Medicine policy, Senate | Tagged , , , , , , | Leave a comment

Channel Nine ACA ADHD breakthrough; TGA response to FOI

For Background see: https://croakey.org/a-current-affairs-adhd-breakthrough-bona-fide-news-or-unethical-advertising/ On 27 March 2018, following FOI requests, the TGA confirmed that their Advertising Compliance Unit (ACU) did investigate a complaint about this program submitted by Prof Jon Jureidini to the Complaint Resolution Panel on 21 February 2017 … Continue reading

Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment